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Smoking, Mental Health, and Alcohol and Other Drug Treatment: A Review
Abstract
Smoking tobacco is the largest single risk factor for premature death in developed
countries. It is also associated with the greatest economic cost of all drugs in
Australian society. In addition to the health and economic consequences associated
with smoking, it has also been associated with mental health problems. Smoking has
been associated with anxiety, depression and stress, as well as more pervasive
disorders such as panic disorder and agoraphobia. It is not clear whether smoking
contributes to mental health problems or individuals with mental health problems
smoke to alleviate symptoms. It may be there are genetic factors that contribute to
both. The various forms of smoking cessation interventions include nicotine
replacement therapies (NRT), brief interventions, telephone counselling, self-help
materials, banning smoking in certain areas, and individual counselling or group
therapy. Research suggests that combinations ofNRT for extended periods of time is
the most effective smoking cessation intervention. Rates of smoking remain high
amongst people with alcohol and other drug use disorders. Mortality rates from
smoking are much higher for these individuals compared to the general community.
Despite smoking cessation not being encouraged for those in treatment for alcohol
and other drug use, research suggests that treating smoking for these individuals does
not put at risk other drug treatment and may actually improve treatment outcomes.
The "stages of change" model theorises that smokers are in one of five stages of
readiness to change their smoking behaviour at any one time. There are also ten
different processes that people use to progress through the stages. A large body of
research supports the "stages of change" model. There appears to be little research on
smoking and stages of change amongst alcohol and other drug treatment populations.
The high mortality rate resulting from smoking for this population warrants further
research.

Author: Thomas Hopkins
Supervisors: Dr Deborah Gardner
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Submitted: October, 2008
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Introduction
The relationship between smoking tobacco and chronic health problems is
well established (Bergen & Caporaso, 1999). Various health problems such as cancer
of the lungs, oesophagus, cervix, anus, throat and bladder, as well as an increased risk
of heart disease and stroke are only some of the problems associated with smoking
(Ryder Salmon & Walker, 2001). In addition, smoking is the largest single risk factor
for premature death in developed countries (WHO, 2007). The costs of tobacco use
goes beyond just health problems in society. A recent report found tobacco use to be
associated with the greatest economic cost in society when compared to alcohol and
illicit drugs (Collins & Lapsley, 2007).
Less appears to be known about the relationships between smoking and
mental health problems. Nonetheless, the rates of smoking have been found to be
higher amongst psychiatric patients than in the general community (Hughes,
Hatsukami, Mitchell & Dahlgren, 1986). Smoking has also been found to have strong
associations with depression (Kinnunen, Haukkala, Quiles, Spiro & Garvey, 2006;
Williams & Ziedonis, 2004), anxiety (West & Hajek, 1997) and stress (Parrot, 1993).
In addition to anxiety, depression and stress, smoking has also been found to
be associated with other drug dependencies (Williams & Ziedonis, 2004). In a study
by Breslau et al. (1996), it was found that smoking and alcohol dependency were
significantly associated in the population samples. The rates of smoking among
individuals with substance use disorders have been found to be double to triple that of
the general community (Batel, Pessione, Maitre & Rueff, 1995). In addition, many of
the individuals that are successfully treated for their drug dependencies will
experience a reduced quality of life and longevity due to smoking (Hurt et al., 1996).
Indeed it is tobacco (not alcohol or illicit drugs) that has been found to be the leading
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cause of death among former patients of a community addictions treatment program
(Hurt et al.). In contrast to the commonly held belief among addiction treatment
programs that attempting to quit smoking whilst being treated for drug addiction may
jeopardise effective treatment, there are some findings that suggest that including
smoking cessation interventions in addiction treatment programs may actually
improve treatment outcomes (Bobo, Mcilvain, Lando, Walker & Leed-Kelly, 1998).
The psychoactive ingredient in tobacco is nicotine, which is a CNS stimulant
(Ryder et al., 2001). It has been found that nicotine increases the levels of the
neurotransmitter dopamine in the part ofthe brain that regulates feelings of pleasure
(Epping-Jordan, Watkins, Koob & Markou, 1998). Nicotine has been found to
contribute to dependence which results in physical and neurobiologic withdrawal
symptoms on cessation (Epping-Jordan et al., 1998).
A number of different smoking intervention strategies have been found to be
effective in aiding smoking cessation. The various forms of nicotine replacement
therapies that have been found to be effective are the transdermal patch, nasal spray,
inhaler, chewing gum, tablet or lozenge (Silagy, Mant, Fowler & Lodge, 1994). This
enables the smoker to reduce the withdrawal symptoms whilst giving up smoking.
Other strategies used in the cessation of smoking include brief interventions,
telephone counselling, self-help materials, banning smoking in certain areas, and
individual counselling or group therapy (Fitchenburg & Glantz, 2002; Foulds et al,
2006; Hajek, Taylor & Mills, 2002; Murray et al., 2008; Pan, 2006).
Prochaska and Velicer (1997) posited that a smoker is in one of five stages of
change at any given time. The five stages of change are precontemplation,
contemplation, preparation, action, and maintenance. The stage of change an
individual is in has been found to influence their relative success at smoking cessation
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(DiClemente et al., 1991). In addition to the five stages of change, Prochaska and
Velicer also identified 10 processes of change which an individual uses at different
stages. These processes are consciousness raising, self-liberation, social-liberation,
self-reevaluation, environmental reevaluation, stimulus control, counterconditioning,
dramatic relief, contingency management, and helping relationships.
The purpose of this paper is to review the literature on smoking and mental
health, the various smoking cessation interventions, the research regarding smoking
and smoking cessation amongst drug treatment populations, and the findings
regarding smoking cessation and the stages of change model. The paper will begin
with some recent findings on the societal costs of tobacco use in Australia, as well as
some recent statistics on the mortality and morbidity attributable to tobacco use in
Australia. This will be followed by a review of the various findings on the association
between tobacco and mental health as well as the findings regarding smoking
cessation strategies. Following this will be a review on the various findings regarding
smoking cessation in drug addiction treatment settings, as well as a look at the
findings regarding the influence of an individual's stage of change on their smoking
cessation success.
Literature Review
The costs of tobacco use in Australia are not just limited to the large number
of deaths caused every year. Collins and Lapsley (2007) have outlined the total social
costs, in an economic sense, of drug abuse in Australia. They define economic costs
of drug abuse as "the value of the net resources that in a given year are unavailable to
the community for consumption or investment purposes as a result of the effects of
past and present drug abuse, plus the intangible costs imposed by this abuse" (Collins
& Lapsley, 2007, p. 2). Of the total social cost of drug abuse in Australia in 2004/05,
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tobacco accounted for $31.5 billion, which was 56.2 percent (Collins & Lapsley).
Alcohol was the next highest at $15.3 billion and all illicit drugs together accounted
for $8.2 billion. Probably the most frightening finding by Collins and Lapsley was
that regarding involuntary smoking by Australian youth. The term involuntary
smoking referred to passive smoking as well as the effects of smoking on an unborn
child. It was found that for children under 15 years of age in 2004/05, involuntary
smoking accounted for 25 percent of deaths, 96 percent of hospital bed-days and 91
percent of hospital costs. These deaths and hospital admissions resulted from
conditions such as lower respiratory tract infections, Crohn's disease, ulcerative
colitis, antepartum haemorrhage, low birthweight, SIDS, asthma, otitis media, as well
as fire injuries. Tobacco use accounted for 14, 901 involuntary and voluntary deaths
of people aged fifteen years and over.
There appears to be relationships between the amount an individual smokes
and anxiety and depression. In a study that looked at these relationships in teenagers,
it was found that participants who reported high levels of depression and anxiety were
twice as likely to be smokers after controlling for potential confounds (Patton et al.,
1996). Moreover, regular smokers were almost twice as likely as occasional smokers
to report high levels of anxiety and depressive symptoms. This finding indicates that
there may be relationships between level of nicotine dependence and anxiety and
depression. Goodman and Capitman (2000) also found that current tobacco use
among teenagers was a powerful determinant of developing a high level of depressive
symptoms.
Some findings suggest that even occasional smoking among adolescents can
contribute to mental health symptoms. In a study on anxiety and depressive symptoms
among adolescent smokers, Dudas, Hans and Barabas (2005) found there to be a
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significant difference between occasional smokers and regular smokers. Occasional
smokers were defined as those who smoke on some days but not everyday and regular
smokers were defined as those who smoke at least once a day. Those who were
regarded as occasional smokers were found to exhibit higher levels of anxiety on state
as well as trait measures, compared to their non smoking peers. Regular smokers were
found to show higher levels of depression than either occasional smokers or their non
smoking peers. Similar findings were found by Breslau, Kilbey and Andreski (1992)
who found that depression was more strongly associated with heavy smoking and
nicotine dependence than lower levels of use. These findings suggest that even
occasional smoking can have an effect on mental health and that heavier smoking may
be more associated with depressive symptoms.
In addition to depression and anxiety, smoking has also been found to be
associated with more pervasive mental health disorders. Heavy smoking of tobacco
during adolescence has been associated with an increased risk of developing
agoraphobia, generalised anxiety disorder, and panic disorder during early adulthood
after controlling for age, gender, difficult childhood temperament; alcohol and other
drug use; anxiety and depressive disorders during adolescence; and parental smoking,
educational level, and psychopathology (Johnson et al., 2000).
In a study by Parrot (1993) it was found that although smokers experienced a
self-reported decrease in stress after smoking cigarettes, they experienced higher
general levels of stress than non-smokers. It was also found that after smoking
cessation, smokers' general levels of stress were reduced. These findings suggest that
smoking may contribute to increased stress levels in smokers.
It has been suggested that there is a causal link between depression and

smoking. This link appears to go in both directions. For example, depression may
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result from the neurochemical changes caused by smoking, and in contrast,
individuals with depression may self-medicate the negative feelings by smoking
(Carmody, 1989; Gilbert, 1979). A twin study conducted by Kendler et al. (1993)
found there to be higher rates of smoking and major depression in the co-twins of
identical twins than in the co-twins of fraternal twins, suggesting that there may be
genetic factors that predispose individuals to smoking and major depression. Evidence
also suggests that it is only current smoking that is associated with depressive
symptoms. A study of depression and smoking in men over 25 years conducted by
Kinnunen et al. (2006) found that current smokers scored significantly higher on
depression scales than quitters, those who have never smoked and former smokers.
Interestingly, it was also found by Kinnunen et al. that none of the depression
measures predicted smoking cessation. Smokers with higher depression scores were
just as likely to give up smoking as those with lower scores.
Mental health disorders also appear to be associated with the maintenance of
smoking because of the effect from the withdrawal of smoking. In a study on nicotine
withdrawal symptoms among individuals with psychiatric disorders it was found that
individuals with histories of major depression or any anxiety disorder reported more
severe nicotine withdrawal symptoms than those with no history of either disorders
(Breslau et al., 1992). This finding is consistent with a study by Covey, Glassman and
Stetner (1990), in which it was found that smokers with histories of major depression
experienced more psychological distress, anger, and other disturbances that
characterise withdrawal than those without such histories. Interestingly, Breslau et al.
(1992) found that a history of any anxiety disorder, but no history of alcohol or other
drug disorder, was associated with more severe nicotine withdrawal. This finding
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suggests that smoking cessation attempts may not put at risk recovery from alcohol
and other drug use.
The more severe withdrawal symptoms experienced by individuals with
anxiety and depressive disorders may influence their success at cessation attempts. A
study by Glassman et al. (1988) found that smokers who had a history of major
depressive disorder failed at twice the rate of those without, eventhough they were
not depressed at the time. Similar findings were found by Pomerlau, Adkins and
Pertschuk (1978) when they demonstrated that smokers who identified negative affect
as a reason for smoking were more likely to fail in their cessation attempts. Negative
affect was a broad concept used in the earlier studies on smoking referring to states
such as depressed mood, anxiety, tension and/or anger (Glassman, 1993).
Due to the many negative consequences associated with smoking, many
smoking cessation intervention strategies have been developed throughout the years.
Nicotine replacement therapies (NRT) work by replacing the nicotine delivered by
cigarettes so as to reduce the negative affect associated with nicotine withdrawal
(Gold, Ruby & Harvey, 2002). In a meta-analysis on the efficacy ofNRT for smoking
cessation conducted by Silagy, Mant, Fowler and Lodge (1994), it was found that
NRT were effective in aiding smoking cessation. However, all forms ofNRT were
associated with a high relapse rate suggesting that minimising relapse is important if
long-term smoking cessation is to be maintained. Other studies have shown NRT as
well as bupropion hydrochloride (referred to as bupropion) as being effective smoking
cessation strategies (Gold et al.; Jorenby, 2001). Bupropion is an anti-depressant that
works on the central nervous system to reduce the withdrawal symptoms during
smoking cessation (Gold et al.).
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There is also evidence to suggest that using combinations of medications for
smoking cessation can be effective. Some studies have shown combinations ofNRT
to be more effective when compared with an NRT on its own (Croghan et al., 2003;
Fagerstrom, Schneider & Lunell, 1993 ). A study by Steinberg, Foulds, Richardson,
Burke and Shah (2006) which assessed the efficacy of combinations of medications
for smoking cessation found that the use of combinations of medications was
associated with a higher likelihood of remaining abstinent. Although this trend
reduced somewhat over time, a six month follow-up indicated that it was continuing.
Interestingly, those who received combinations of medications were assessed as being
more nicotine dependent at the beginning of the study, but they still did as well as less
dependent smokers at both follow-ups. Steinberg et al. also found that longer duration
of medication use was associated with better outcomes. It was found that those that
continued to use medications had considerably better abstinence rates at six months.
In recent years, doctors have been encouraged to routinely offer smoking
cessation advice to all presenting patients who are smokers (Mullins, Livingston &
Borland, 1999; Murray et al., 2008). The findings on the effectiveness of this
approach are mixed. Murray et al. found that proactively identifying smokers who
wanted to quit in primary care populations and referring them to a cessation service
increased contacts with cessation services and the number of quit attempts. However,
it was found that at the population level there was no significant impact on actual quit
rates or reported cigarette consumption. Hajek, Taylor and Mills (2002) found that a
single session brief intervention to prevent cardiac inpatients from returning to
smoking after discharge was ineffective. The researchers concluded that single session
brief interventions are insufficient to influence highly dependant smokers to quit. A
study conducted by Butler, Pill and Stott (1998) on patients' perceptions of doctors'
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advice to quit smoking found that many patients were sceptical about the influence of
doctors' words on their smoking habits, making the point that the negative effects of
smoking are already well known. In addition, patients who were not ready to quit
reported shrugging it off, feeling guilty, getting annoyed, or changing their help
seeking behaviour, when being advised to quit. Two patients even reported putting
their health at risk by not attending for needed medical help because they feared being
talked to about their smoking. It was also found, however, that the patient's
receptiveness to advice depended largely upon how the advice was delivered.
Interventions that patients found acceptable were those conveyed in a respectful tone
that was not preaching, showed support and caring, and attempted to understand them
as a unique individual. Stott and Pill (1990) had similar findings from their study on
the effect of doctor's advice. This suggests that the manner in which advice is given
by doctors is equally as important as the advice itself.
In a systematic review of the effect of smoke-free workplaces on smoking
behaviour, it was found that totally smoke-free workplaces were associated with
reductions in prevalence of smoking of 3.8% (Fitchenburg & Glantz, 2002). In
addition, smoke-free work places were also associated with smokers smoking 3.1
fewer cigarettes per day. It was estimated by the authors that if all workplaces became
smoke free in the United States and the United Kingdom, consumption per capita in
the entire population would drop by 4.5% in the United States and 7.6% in the United
Kingdom. This study demonstrated the strong effect that smoking restrictions can
have in reducing rates of smoking.
In a meta-analysis on proactive telephone counselling as an adjunct to minimal
intervention for smoking cessation conducted by Pan (2006), it was found that
proactive telephone counselling is effective as an adjunct to other minimal
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interventions for younger, male, light-smoking individuals. Minimal interventions
were defined as a single or combination of less intensive or self-help interventions
such as nicotine replacement therapy, reactive telephone hotlines or helplines,
computer programs or the internet, and physician's advice. The results of the metaanalysis indicated that researchers and health care providers may need to focus on the
individual as much as on the intervention process to provide effective interventions.
This means that smoking interventions should take into account the characteristics of
the individuals that they will be delivered to and be developed accordingly.
There is evidence to suggest that an individual's success at smoking cessation
can depend on their level of nicotine dependence. Foulds et al. (2006) found that the
measure of how long an individual takes to smoke after waking in the morning was
predictive of their smoking cessation outcome. After having controlled for other
predictors, those participants who usually smoked more than 30 minutes after waking
in the morning were twice as likely to succeed at quitting than those who smoked
within five minutes of waking. How long an individual takes to have their first
cigarette for the day is generally a marker of nicotine dependence, so this finding
suggests that an individual's level of nicotine dependence has a bearing on their
cessation attempts. Other studies have reported similar findings on cessation success
and time of first cigarette for the day (Harris et al., 2004; Hymowitz et al., 1997;
Judge et al., 2005). For example, Foulds et al. found that those participants who
sometimes woke in the night to have a cigarette or use tobacco were significantly less
likely to remain abstinent at six month follow-up, after controlling for other
predictors. This is also a marker of nicotine dependence and further supports the
concept that smoking cessation success depends on an individual's level of nicotine
·dependence.
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Socioeconomic status has also been found to be a predictor of success at
smoking cessation. Foulds et al. (2006) found that participants with only a high school
education were significantly less likely to have remained abstinent at both follow-up
periods compared with participants who had a university degree. In addition, being
unemployed predicted a poor outcome at four weeks follow-up, and not having
private health insurance predicted a poor outcome at 26 week follow-up. The
researchers suggested that the effect of socioeconomic background on outcomes is a
result ofthe social environment of those with a lower socioeconomic background. For
example, those with a lower socioeconomic background are less likely to work in
smoke-free environments and are more likely to have friends and family who smoke.
Due to many factors, smoking has declined in developed countries in recent
years (WHO, 2007). Despite this, there has been no significant reduction in smoking
among individuals with substance use disorders (Kalma11, 1998). Indeed, many drug
treatment counsellors discourage clients from quitting smoking in early stages of
treatment (Brigham, Schroeder & Schindler, 2007). One reason that smoking
cessation is not advocated by drug treatment programs is that there is a concern that
this could deter some individuals who are willing to address their other substance use
problem but not their smoking (Bobo, Mcilvain, Lando, Walker & Leed-Kelly, 1998).
Another reason is the belief that encouraging smoking cessation during drug treatment
could jeopardise effective treatment (Campbell, Wander, Stark & Holbert, 1995).
Contrary to this commonly held belief, the research suggests that smoking cessation
does not risk successful substance use treatment. A study by Martin et al., (1997) in
which 205 recovering alcoholics were assigned to one of three smoking cessation
groups found that at 12-month follow-up, only 4% of all participants had relapsed to
use alcohol or other drugs. However, the lack of a non smoking cessation control
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group limited the study. Further support for these findings came from a study
conducted by Burling, Marshall and Seidner (1991) in which 39 inpatient alcohol
dependent men were randomly assigned to a tobacco intervention or waitlist control
group. No adverse effect was found for the tobacco intervention group as compared to
the waitlist control group. In addition, Bobo et al. (1998) from their study of a
randomised controlled trial community intervention involving 575 individuals from
12 residential treatment programs had a primary finding that urging alcohol dependant
individuals to quit smoking does not compromise treatment, even in early stages of
recovery. No adverse effect was detected on participants being able to remain
abstinent after treatment discharge. It was actually found that the likelihood of
remaining abstinent for those who were repeatedly encouraged to quit smoking was
almost twice that of the control group over the one year follow-up. The researchers
attributed the more favourable outcomes for those exposed to the tobacco intervention
to a number of factors. It was likely that some of the aspects from the tobacco
counselling reinforced key elements of effective alcohol treatment. In addition, the
counselling sessions encouraged personal responsibility and supported a drug-free
lifestyle, messages which may have generalised back to alcohol. The study was
limited by the fact that all study data, apart from the analysis of saliva samples, were
gathered via self-report. However, the researchers suggested that was unlikely to bias
their primary finding as they were unable to detect evidence of differential reporting
between intervention and control groups. This is an interesting finding and is contrary
to what is believed throughout the addictions field.
A number of studies have demonstrated the harm oftobacco use among
alcohol and other drug dependant individuals. In an 11-22 year follow-up study of 845
individuals treated for drug dependency conducted by Hurt et al. (1996), it was found
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that those treated for drug dependency had a mortality rate almost three times that of
the general community of the same age. Interestingly, the majority of deaths were not
a result of the drugs that they were treated for but were attributed to conditions
resulting from tobacco use such as lung cancer and heart disease. Another study
conducted by Hser, McCarthy and Anglin (1994) found that opiate addicts who
smoked had a mortality rate four times that of opiate addicts who did not smoke at 2124 year follow-up. In addition, it was found that the relapse rate amongst the survivors
who did not smoke was less than that of the survivors who continued to smoke.
However, because Hser et al.'s data was based on observational, retrospective data,
they did not know whether smoking cessation occurred around the time of treatment
or years later.
Not all research suggests that smoking cessation does not jeopardise effective
drug treatment. There is also evidence suggesting that smoking cessation can have a
detrimental effect on alcohol and other drug treatment. Conner, Stein, Longshore and
Stacey (1999) found that the introduction of a mandatory smoking abstinence policy
for polydrug users in treatment resulted in an increase in cocaine use. It was suggested
by the researchers that tobacco had likely served as a replacement for cocaine
previous to the ban. Other studies have also found that individuals in drug treatment
increase their tobacco use as a replacement drug (Campbell et al.,1995). However, the
majority of research reviewed suggests that smoking cessation does not jeopardise
alcohol and other drug treatment and may actually improve treatment outcomes.
The "stages of change" model was developed from observations of how
people quit smoking on their own and has proven to be effective in the development
of smoking cessation interventions (Prochaska, DiClemente, Velicer & Rossi, 1993 ).
Originally developed for quitting smoking, the model can be used for any behaviour
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change, in particular in the field of alcohol and other drugs (Ryder, 1999). The five
stages can have a bearing on how successful an individual will be quitting smoking or
changing any other kind of behaviour (Prochaska & Velicer, 1997). People in
precontemplation are not intending to quit smoking in the near future, usually
measured as the next six months. Individuals in the precontemplation stage may be
underinformed of the full extent of the consequences of their behaviour or may be
demoralised after failed attempts at behaviour change in the past. The latter is more
likely the case for smokers who are in precontemplation. Precontemplators are
resistant and are not ready for any interventions. People in the contemplation stage are
intending to quit in the next 6 months. They are more aware of the benefits of
changing their behaviour than people in precontemplation but are also very aware of
the costs. People in contemplation to be in a state of ambivalence and people can be in
the contemplation stage for a very long time. They are typically not ready for actionoriented interventions. People in the preparation stage are intending to quit in the
immediate future; usually measured as in the next 30 days. Generally these people
have taken some form of action over the past year, and usually have a plan of action
such as having sought counselling, consulted their physician, or bought a self-help
book. People in the action stage have stopped smoking within the last 6 months.
When the model is applied to smoking, only complete abstinence qualifies as being
action. Simply cutting down on the number of cigarettes or switching to lower tar or
nicotine brands does not qualify as being action. This is because there is no safe level
of use for tobacco (WHO, 2007). People in the maintenance stage are in the process of
preventing relapse but do not have to focus on maintaining their change as much as
those in action. The temptation to relapse becomes less and less for those in
maintenance and they become increasingly confident that they can continue with their
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changed behaviour. It is estimated that people can be in the maintenance stage from
anywhere between six months and five years. Although not formally a stage in the
model, relapse is an expected part of the progression through the stages. However,
individuals would rarely relapse all the way back to precontemplation. Usually relapse
would take people back to contemplation or preparation.
In addition to the five stages of change, Prochaska and Velicer (1997)
identified ten covert and overt processes that people use as they progress through the
stages. The covert, internal processes are associated more with the early stages of
change and the more overt, behavioural processes are associated more with the later
stages of change. Consciousness raising is the process by which an individual
becomes more aware of the consequences associated with their behaviour. An
individual would likely go through this process in precontemplation. Dramatic relief
is the process where by an individual has an emotional experience related to their
behaviour. For example, an individual may have a family member who dies as a result
of a smoking-related illness which may trigger that person to move from
precontemplation to contemplation. Self-reevaluation involves an individual assessing
themself, both cognitively and affectively, with and without the behaviour they want
to change. This process usually occurs in the contemplation stage. Environmentalreevaluation involves an individual making a cognitive and affective assessment of
the impact that their behaviour is having on their social environment, such as the
effect of smoking on others. This process usually occurs in the precontemplation or
contemplation stages. Self-liberation is the process whereby an individual begins to
believe in their ability to change and the commitment to act on that belief. Commonly
referred to as willpower, this process generally occurs in the preparation stage. Social
liberation is the process whereby an individual's social environment provides more of

Smoking, Mental Health, and AOD Treatment 18
an opportunity for the behaviour change. Smoke-free workplaces are an example of
social-liberation. Counterconditioning involves the replacing of the unwanted
behaviour with new healthy behaviours. For example, doing exercise as a replacement
for a morning cigarette. This process would generally occur in the action stage.
Stimulus control is the process whereby an individual removes stimuli from the
environment that may prompt a relapse to the changed behaviour. For example,
someone who has just given up smoking would benefit from throwing out all ashtrays
and lighters. This is typically an action process. Contingency management is the
process whereby an individual treats themself for reaching certain goals in their
behaviour change. For example, someone who is stopping smoking could use the
money saved from cigarettes to buy something they want as a reward. This is also
typically an action process. The final process, helping relationships, involves
establishing a network of supportive people that can help maintain the desired change.
A counsellor can be an example of a helping relationship. This is also an action
process.
Many research findings support the "stages of change" model for smoking
cessation. A study conducted by DiClemente et al. (1991) analysed the accuracy of
the stages precontemplation, contemplation, and preparation amongst smokers. The
results strongly supported the stages of change model. Smokers were assessed for
their stage of change and then were followed-up at one and six months. At both
follow-ups, significantly more people who were previously assessed as being in the
preparation stage had made quit attempts than in other stages and significantly more
contemplators had made quit attempts than precontemplators. A study conducted by
Prochaska, V elicer, Fava, Rossi and Tsoh (200 1) evaluated a stage-based expert
system intervention for smoking cessation. The stage-based expert system
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individualised the interventions to the participants' stage of change and, using
computers, interacted with them around the processes and principles that are
necessary for them to progress. Prochaska et al. found that they were able to achieve a
25% abstinence rate at 24 month follow-up. This was a good result considering that
out of their population, more than 40% were not intending to quit. These findings
demonstrated the efficacy of the stages of change model in that interventions tailored
to individual's stage of change produced abstinence in people that other interventions
would normally fail with. The highest abstinence rates were found in people in
preparation, contemplation, and precontemplation, respectively. These findings
suggest that the success of an intervention depends upon the amount of preparation
smokers have undertaken prior to taking action.
The "stages of change" model has been shown to be effective across different
fields. A study by Brogan, Prochaska and Prochaska (1999) found that when the
model was applied to the change process in psychotherapy it was shown to be a good
predictor of who would remain in treatment. A study conducted by Acton, Prochaska,
Kaplan, Small and Hall (2001), which examined the association between depression
and stages of change for smoking cessation in a psychiatric outpatient sample
supported several tenets ofthe model. The use of behavioural processes increased
from precontemplation to maintenance. In addition, the use of experiential processes
was high across all stages. However, the therapy often focused on processes such as
consciousness raising and self-reevaluation so it is possible that these processes may
have spilt over to the context of smoking cessation, thus accounting for these
processes occurring in the later stages of change. An interesting finding was the
relationship between stage of change and depression. It was found that contemplators
had elevated depression scores. The researchers attributed this to possibly being the
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dread felt by smokers who are intending to quit in the next six months. In addition to
the dread, the researchers suggested that these contemplators may feel dejection over
the discrepancy between their goal of abstinence and their current smoking behaviour,
and such dejection can lead to depression. This could be a possible reason for the
increased depressive symptoms found amongst smokers compared to non smokers.
Pearlman, Wernicke, Thorndike and Haaga (2004) have also supported the
"stages of change" model. They found that individuals in later stages of change have
more positive outcome expectancies regarding quitting smoking and more negative
outcome expectancies regarding continuing smoking. This finding is supported by
previous studies (DiClemente et al., 1991; Prochaska et al., 1994). Pearlman et al.
suggested that smoking cessation programs should utilise this finding and develop
programs that increase awareness about the benefits and costs of smoking.
Further support for the "stages of change" model was found by DiClemente et
al. (1991). They found that there were differences in the number oflifetime quit
attempts made by people at different stages of change with precontemplators reporting
the lowest number oflifetime quit attempts. In addition, DiClemente et al. also found
significant differences across stages of change in regards to individual's self-efficacy
beliefs for quitting smoking. Precontemplators were found to report the most
temptation to smoke and the lowest level of confidence in their ability to stop
smoking. Confidence about one's ability to quit smoking significantly increased from
precontemplation to contemplation.
Conclusion
The purpose of this paper was to review the literature on smoking and mental
health, the various smoking cessation interventions, the research regarding smoking
and smoking cessation amongst drug treatment populations, and the findings
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regarding smoking cessation and the stages of change model. In addition to the many
deaths caused from smoking, it also causes the most economic costs in Australian
society of all psychoactive drugs (Collins & Lapsley, 2007). Tobacco is also
responsible for a large amount of the mortality and illness of Australian youth, due to
involuntary smoking (Collins & Lapsely).
There is a large amount of evidence linking smoking and mental health
symptoms, particularly anxiety and depressive symptoms (Breslau et al., 1992; Patton
et al., 1996). However, smoking has also been found to be associated with more
pervasive mental health disorders, such as panic disorder and agoraphobia (Johnson et
al., 2000). It has been suggested that there is a causal link between smoking and
mental health problems (Carmody, 1989; Gilbert, 1979). The direction of this link,
however, is unknown. It could be that those with mental health problems smoke to
reduce the negative affect that they experience as a result of their disorder.
Conversely, it could be that smoking contributes to the mental health disorder. There
is also evidence to suggest that genetic factors contribute to both (Kendler et al.,
1993). Research also suggests that mental health disorders may be associated with the
maintenance of smoking because of the more severe nicotine withdrawal symptoms
experienced by individuals with mental health disorders (Breslau et al., 1992; Covey
et al., 1990)
The many negative consequences resulting from smoking have prompted
many smoking cessation interventions to be developed. NRT have been found to be
one of the most effective of these strategies (Silagy et al., 1994). However, they have
also been associated with a high rate of relapse (Silagy et al.). NRT used in
combinations and for extended periods of time have been found to be the most
effective (Croghan et al., 2003; Fagerstrom et al., 1993; Steinberg et al., 2006). The
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findings on the effectiveness of brief advice delivered by physicians are mixed.
However, a constant finding is that the way the advice is delivered is an important
determinant of how well the advice will be received (Butler et al., 1998; Stott & Pill,
1990). Other smoking interventions that have been found to be effective are the
banning of smoking in certain areas, and proactive counselling as an adjunct to
minimal interventions for younger light smoking male individuals (Fitchenburg &
Glantz, 2002; Pan, 2006). An individual's level of nicotine dependence, as well as
their socioeconomic status, has also been found to be related to how successful an
individual will be at quitting smoking (Foulds et al., 2006).
Although rates of smoking have declined in developed countries, there has
been no decline in smoking amongst people with substance use disorders (Kalman,
1998). Treating smoking in this population is important because the evidence suggests
that the majority of these people will die from smoking-related illnesses and not from
alcohol or other drugs (Hser et al., 1994; Hurt et al., 1996). Although it is commonly
believed that attempting to address smoking with these individuals could jeopardise
effective drug treatment, the majority of evidence suggests otherwise (Bobo et al.,
1998; Martinet al., 1997; Burling et al., 1991). In fact, there is evidence to suggest
that treating these individual's smoking may actually improve outcomes with other
drugs (Bobo et al.).
The stages of change model theorises that a smoker is in one of the five stages
of change at any one time (Prochaska & Velicer, 1997). In addition, as an individual
moves through the five stages of change, they use a number of different processes of
change to help them progress through the stages. There exists a large body of research
supporting the stages of change model for smoking and other behaviours (Acton et al.,
2001; Brogan et al., 1999; Diclemente et al., 1991; Pearlman et al., 2004; Prochaska et
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al., 2001 ). Characteristics of individuals in the different stages have been reported by
research as well as the different processes that are used by individuals in the different
stages.
To date, there appears to be a paucity of research regarding stages of change
and smoking amongst people attending alcohol and other drug treatment. It may be
that the better alcohol and other drug abstinence rates found in those who ceased
smoking could be related to the processes that these individuals use whilst ceasing
smoking and maintaining smoking cessation. These processes would likely help an
individual to stay abstinent from other drugs. It may also be that when these people
are entering for alcohol and other drug treatment they are already in the stage of
preparation or even maintenance (if they have already been abstinent for a period of
time) which may be transferred to their tobacco use as well as their other drug or
drugs. With the rates of smoking as high as they are in this population, addressing
smoking for these individuals' remains a very important issue in public health and
further research in this is necessary.
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The Relationship between Nicotine Dependence and Symptoms of Anxiety,
Depression and Stress in a Therapeutic Community for Alcohol and other Drug
Rehabilitation
Thomas Hopkins
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Abstract
Smoking is the largest single risk factor for premature death in developed countries.
The research suggests that there are also relationships between smoking and
symptoms of anxiety, depression and stress. The rates of smoking are much higher
amongst individuals with substance use disorders than that of the general community
yet smoking cessation is rarely offered in drug treatment programs. The present study
aimed to test the relationship between nicotine dependence and symptoms of anxiety,
depression and stress in a Therapeutic Community (TC) for alcohol and other drug
rehabilitation. Participants were 30 people who were residents of a TC for alcohol and
other drug rehabilitation. A correlational research design was utilised to test the
relationships between the variables. A oneway ANOVA was also utilised to determine
whether entering the TC for dependence on alcohol alone or alcohol and/or other
drugs had an influence on participants symptoms of anxiety, depression and stress. A
descriptive design was used to analyse self-report survey data. Three questionnaires
were used to gather the data. A significant moderate positive correlation was found
between nicotine dependence and stress. No significant main effects were found from
the ANOVA. The results from the study support past research that suggests that
smoking is associated with stress. Support was also provided for the "stages of
change" model. If introduced into the TC, smoking interventions could initially
involve education aimed at moving clients through the stages of change before
offering smoking cessation.
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The Relationship between Nicotine Dependence and Symptoms of Anxiety,
Depression and Stress in a Therapeutic Community for Alcohol and other Drug
Rehabilitation
Introduction
Smoking is the largest single risk factor for premature death in developed
countries (WHO, 2007). In addition, the relationship between smoking tobacco and
chronic health problems is well established (Bergen & Caporaso, 1999). Various
health problems such as cancer of the lungs, oesophagus, cervix, anus, throat and
bladder, as well as an increased risk ofheart disease and stroke are only some of the
problems associated with smoking (Ryder Salmon & Walker, 2001). Less appears to
be known about the relationships between smoking and mental health problems.
Nonetheless, the rates of smoking have been found to be higher amongst psychiatric
patients than in the general community (Hughes, Hatsukami, Mitchell, Dahlgren,
1986). Smoking has also been found to have strong associations with depression
(Kinnunen, Haukkala, Quiles, Spiro & Garvey, 2006; Williams & Ziedonis, 2004),
anxiety (West & Hajek, 1997) and stress (Parrot, 1993).
Tobacco contains the CNS stimulant nicotine (Ryder et al., 2001). Nicotine
increases the levels of the neurotransmitter dopamine in the part of the brain that
regulates feelings ofpleasure (Epping-Jordan, Watkins, Koob & Markou, 1998). It
has been found to contribute to dependence, resulting in physical and neurobiologic
withdrawal symptoms on cessation (Epping-Jordan et al., 1998).
Mental Health Effects ofSmoking
There appears to be relationships between the amount an individual smokes
and anxiety and depression. In a study that looked at relationships between smoking
and anxiety and depression in teenagers, it was found that participants who reported
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high levels of depression and anxiety were twice as likely to be smokers after
controlling for potential confounds (Patton et al., 1996). Moreover, regular smokers
were almost twice as likely as occasional smokers to report high levels of anxiety and
depressive symptoms. This finding indicates that there may be relationships between
level of nicotine dependence and anxiety and depression. Goodman and Capitman
(2000) also found that current tobacco use among teenagers was a powerful
determinant of developing a high level of depressive symptoms.
In addition to depression and anxiety, smoking has also been found to be
associated with more pervasive mental health disorders. Heavy smoking of tobacco
during adolescence has been associated·with an increased risk of developing
agoraphobia, generalised anxiety disorder, and panic disorder during early adulthood
(after controlling for age, gender, difficult childhood temperament, alcohol and other
drug use, anxiety and depressive disorders during adolescence, parental smoking,
educational level, and psychopathology) (Johnson et al., 2000). Moreover, when
asked to describe their changes in smoking behaviour and feeling states over the
previous two years, adolescents reported an increase in affective distress with the
progression from experimental to more regular smoking (Hirschman, Leventhal &
Glynn, 1984). The first results from the 2007 National Drug Strategy Household
Survey (NDSHS) also found that daily smokers were more likely than other recent
smokers or non-smokers to report high or very high levels of psychological distress
(AIHW, 2007).
It is a commonly held belief amongst smokers that smoking relieves tension
and stress (Ikard, Green & Horn, 1969). However, a closer look at the processes that
occur in the smoker suggest otherwise. In a study by Parrot (1993) it was found that
although smokers experienced a self-reported decrease in stress after smoking
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cigarettes, they experienced higher general levels of stress than non-smokers. It was
also found that after smoking cessation, smokers' general levels of stress were
reduced. When queried about their moods over the day, smokers have reported
patterns of repetitive mood fluctuations, with normal moods during cigarette smoking
followed by increasing stress periods between cigarettes (Parrot, 1994a; Parrot,
1994b). In addition, these mood fluctuations are more prominent in more dependent
smokers, who also report mood control as the main reason for the maintenance of
their smoking (Parrot, 1994b). It has also been found that smokers' stress levels are
similar to non smokers only whilst smoking and become worse during periods of
abstinence (Parrot & Garnham, 1998). The repeated occurrence of elevated stress
levels between cigarettes suggests that smokers experience above average daily stress
levels. These findings suggest that smoking may contribute to increased stress levels
in smokers.
The research on smoking cessation and stress also suggests smoking
contributes to stress levels. In a study that monitored smokers who were attempting to
quit unaided over six months, Cohen and Lichtenstein (1990) found that the smokers
who failed to quit reported unchanging levels of high stress at every follow-up
session. Contrastingly, the former smokers who completely abstained from smoking
during the six months reported a steady decrease in stress over time. These findings
were made all the more important by the fact that both the successful and
unsuccessful quitters reported similar stress levels at baseline, so it was not just the
less stressed smokers who successfully quit. Other research has also found reduction
in stress levels of former smokers after cessation (Carey, Kalra, Carey, Halperin &
Richards, 1993; Parrot, 1995). The apparent high stress levels of smokers may
adversely affect their success when they engage in smoking cessation interventions.
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Smoking Cessation Interventions

Due to the many negative consequences associated with smoking, such as an
increased risk for both physical and mental illness including increased stress, many
smoking cessation intervention strategies have been developed throughout the years.
Nicotine replacement therapies (NRT) work by replacing the nicotine delivered by
cigarettes so as to reduce the negative affect associated with nicotine withdrawal
(Gold, Ruby & Harvey, 2002). In a meta-analysis on the efficacy ofNRT for smoking
cessation conducted by Silagy, Mant, Fowler and Lodge (1994), it was found that
NRTwere effective in aiding smoking cessation. However, all forms ofNRT were
associated with a high relapse rate suggesting that minimising relapse is important if
long-term smoking cessation is to be maintained. Other studies have shown NRT as
well as bupropion hydrochloride (referred to bupropion) as being one of the most
effective smoking cessation strategies (Gold et al.; Jorenby, 2001). Bupropion is an
anti-depressant that works on the central nervous system to reduce the withdrawal
symptoms during smoking cessation (Gold et al.).
There is also evidence to suggest that using combinations of medications for
smoking cessation can be effective. Some studies have shown combinations ofNRT
to be more effective when compared with an NRT on its own (Croghan et al., 2003;
Fagerstrom, Schneider & Lunell, 1993). A study by Steinberg, Foulds, Richardson,
Burke and Shah (2006) which assessed the efficacy of combinations of medications
for smoking cessation found that the use of combinations of medications was
associated with a higher probability of remaining abstinent. Although this trend
reduced somewhat over time, a six month follow-up indicated that it was continuing.
Interestingly, those who received combinations of medications were assessed as being
more nicotine dependent at the beginning of the study, but they still did as well as less
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dependent smokers at both follow-ups. Steinberg et al. also found that longer duration
of medication use was associated with better outcomes. It was found that those who
continued to use medications had considerably better abstinence rates at six months.
In recent years, doctors have been encouraged to routinely offer smoking
cessation advice to all presenting patients who are smokers (Mullins, Livingston &
Borland, 1999; Murray et al., 2008). The findings on the effectiveness of this
approach are mixed. Murray et al. found that proactively identifying smokers who
wanted to quit in primary care populations and referring them to a cessation service
increased contacts with cessation services and the number of quit attempts. However,
it was found that at the population level there was no significant impact on actual quit
rates or reported cigarette consumption. Hajek, Taylor and Mills (2002) found that a
single session brief intervention to prevent cardiac inpatients from returning to
smoking after discharge was ineffective. The researchers concluded that single session
brief interventions are insufficient to influence highly dependent smokers to quit.
Factors Affecting Intervention Success

Socioeconomic status has been found to be a predictor of success at smoking
cessation. Foulds et al. (2006) found that participants with only a high school
education were significantly less likely to have remained abstinent at both follow-up
periods compared with participants who had a university degree. In addition, being
unemployed predicted a poor outcome at four weeks follow-up, and not having
private health insurance predicted a poor outcome at 26 week follow-up. The
researchers suggested that the effect of socioeconomic background on outcomes is a
result of the social environment of those with a lower socioeconomic background. For
example, those with a lower socioeconomic background are less likely to work in
smoke-free environments and are more likely to have friends and family who smoke.
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Socioeconomic status and education level has also been found to be a predictor of
smoking. Research has found rates of smoking to be higher amongst people with a
lower educational background when compared to people with a higher educational
background (Blakey & Wilson, 2005). A study by Kestila et al. (2006) found that
young adults in the lowest educational category had a much higher risk of developing
daily smoking than those in the highest educational category.
The "stages of change" model was developed from observations of how
people quit smoking on their own and has proven to be effective in the development
of smoking cessation interventions (Prochaska, DiClemente, Velicer & Rossi, 1993).
The five stages can have a bearing on how successful an individual will be at quitting
smoking or changing any other kind of behaviour (Prochaska & Velicer, 1997). The
stages are precontemplation, contemplation, preparation, action, and maintenance.
People in the precontemplation stage are not intending to quit smoking in the near
future, usually measured as the next six months. Individuals in the precontemplation
stage may be underinformed of the full extent of the consequences of their behaviour
or may be demoralised after failed attempts at behaviour change in the past.
Precontemplators are resistant and are not ready for any interventions. People in the
contemplation stage are intending to quit in the next 6 months. They are more aware
of the benefits of changing their behaviour than people in precontemplation but are
also very aware of the costs. People in contemplation seem to be in a state of
ambivalence and can be in the contemplation stage for a very long time. They are
typically not ready for action-oriented interventions. People in the preparation stage
are intending to quit in the immediate future; usually measured as in the next 30 days.
Generally these people have taken some form of action over the past year such as
having sought counselling, consulted their physician, or bought a self-help book, and
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also have a plan of future action. People in the action stage have stopped smoking
within the last 6 months. When the model is applied to smoking, only complete
abstinence qualifies as being action. Simply cutting down on the number of cigarettes
or switching to lower tar or nicotine brands does not qualify as being action. This is
because there is no safe level of use for tobacco (WHO, 2007). People in the
maintenance stage are in the process of preventing relapse but do not have to focus on
maintaining their change as much as those in action. It is estimated that people can be
in the maintenance stage for anywhere between six months and five years. The
"stages of change" model is a commonly used model in the addictions and public
health field and is supported by a large body of research (Brogan, Prochaska and
Prochaska, 1999; DiClemente et al., 1991; Pearlman, Wernicke, Thorndike and
Haaga, 2004; Prochaska et al., 1994; Prochaska, Velicer, Fava, Rossi and Tsoh,
2001).
Smoking Interventions and Alcohol and Other Drug Treatment

Due to many factors, such as the increased awareness ofthe health
consequences associated with smoking as well as interventions such as banning
smoking in public places, smoking has declined in developed countries in recent years
(WHO, 2007). Despite this, there has been no significant reduction in smoking among
individuals with substance use disorders (Kalman, 1998). The rates of smoking among
individuals with substance use disorders have been found to be double to triple that of
the general community (Batel, Pessione, Maitre & Rueff, 1995). In addition, many of
the individuals that are successfully treated for their drug dependencies will
experience a reduced quality of life and longevity due to smoking (Hurt et al., 1996).
Indeed it is tobacco (not alcohol or illicit drugs) that has been found to be the leading
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cause of death among former patients of a community addictions treatment program
(Hurt et al.).
Many drug treatment counsellors discourage clients from quitting smoking in
early stages of recovery (Brigham, Schroeder & Schindler, 2007). One reason that
smoking cessation is not advocated by drug treatment programs is that there is a
concern that this could deter some individuals who are willing to address their
substance use problem but not their smoking (Bobo, Mcilvain, Lando, Walker &
Leed-Kelly, 1998). Another reason is the belief that encouraging smoking cessation
during drug treatment could jeopardise effective treatment (Campbell, Wander, Stark
& Holbert, 1995). Contrary to this commonly held belief, the research suggests that

smoking cessation does not risk successful substance use treatment. A study by
Martinet al., (1997) in which 205 recovering alcoholics were assigned to one of three
smoking cessation groups found that at 12-month follow-up, only four percent of all
participants had relapsed to use alcohol or other drugs. However, the lack of a non
smoking cessation control group limited the study. Further support for these findings
came from a study conducted by Burling, Marshall and Seidner (1991) in which 39
inpatient alcohol dependent men were randomly assigned to a tobacco intervention or
waitlist control group. No adverse effect on treatment was found for the tobacco
intervention group as compared to the waitlist control group. In addition, Bobo et al.
(1998) from their study of a randomised community intervention involving 575
individuals from 12 residential treatment programs had a primary finding that urging
alcohol dependant individuals to quit smoking is safe, even in early stages of
recovery. No adverse effect was detected on participants being able to remain
abstinent after treatment discharge. It was actually found that the likelihood of
remaining abstinent for those who were repeatedly encouraged to quit smoking was
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almost twice that of the control group over the one year follow-up. The researchers
attributed the more favourable outcomes for those exposed to the tobacco intervention
to a number of factors. It was likely that some of the aspects from the tobacco
counselling reinforced key elements of effective alcohol treatment. In addition, the
counselling sessions encouraged personal responsibility and supported a drug-free
lifestyle, messages which may have generalised to alcohol use. The study was limited
by the fact that all study data, apart from the analysis of saliva samples, were gathered
via self-report. However, the researchers suggested that was unlikely to bias their
primary finding as they were unable to detect evidence of differential reporting
between intervention and control groups. This is an interesting finding and is contrary
to what is believed throughout the addictions field.
Smoking in the Therapeutic Community for Alcohol and Other Drug Treatment

Whilst there is a large amount of existing research regarding the association
between smoking, stress, anxiety and depression, as well as on the various smoking
cessation strategies, to date there appears to have been little research conducted on
these issues involving residents of a Therapeutic Community (TC) for alcohol and
other drug (AOD) rehabilitation. Research suggests that smoking contributes to high
stress levels (Parrot, 1993), anxiety (West & Hajek, 1997), and depressive symptoms
(Kinnunen et al., 2006; Williams & Ziedonis, 2004). Therefore, determining whether
smoking is contributing to these mental health problems in such a population could
aid in the treatment of these individuals by giving reason to incorporate smoking
reduction education and possibly smoking cessation strategies appropriate to
individuals' progress in the rehabilitation program. Knowledge that smoking cessation
may reduce such unpleasant symptoms could also provide motivation for residents
living in the TC to stop or reduce their smoking. In addition, determining residents'
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stages of change (Prochaska & Velicer, 1997) and past or current experience with
smoking cessation may also contribute to the development of effective smoking
cessation strategies. In the proposed study, the relationships between nicotine
dependence and symptoms of anxiety, depression and stress will be examined.
Therefore, the research question that will be tested is: Do symptoms of anxiety,
depression and stress increase as nicotine dependence increases? It is hypothesised
that as the level of nicotine dependence increases, symptoms of anxiety, depression
and stress will also increase. If nicotine contributes to affective distress, as the
research suggests, then it may be that the more drugs individuals uses the more
affective distress they experience. Therefore, the second research question to be tested
is: does having entered the TC for dependence on alcohol alone or alcohol and/or
other drugs have an influence on participants' symptoms of anxiety, depression and
stress? It is hypothesised that those who have entered the TC for dependence on
alcohol and/or other drugs will score higher on measures on anxiety, depression and
stress than those who have entered the TC for dependence on alcohol alone. In
addition, participants' stages of change regarding smoking will be determined, as well
as their views, motivations, and past experiences regarding smoking cessation. This
information will assist Cyrenian House to make decisions about smoking cessation
interventions appropriate for its clients.
Method
Design

The present study utilised a correlational research design to test the
relationship between nicotine dependence and symptoms of anxiety, depression and
stress. In addition, Crosstabs were also used to describe the relationships between the
non continuous variables and the continuous and non continuous variables.
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Questionnaires were used to measure the variables. A descriptive design was used to
analyse exploratory self-report survey data.
Materials

Three questionnaires were completed by the participants. The first
questionnaire consisted of demographic questions and some questions regarding
views, motivations, and past smoking cessation experiences (see Appendix A). The
second questionnaire was the Fagerstrom Test for Nicotine Dependence (FTND)
(Heatherton, Kozlowski & Frecker, 1991) (see Appendix B) and the third
questionnaire was the Depression, Anxiety and Stress Scale (DASS) (Psychology
Foundation of Australia, 2006) (see Appendix C). An information sheet (see
Appendix D) was presented to the participants prior to administering the
questionnaires.
Fagerstrom Test for Nicotine Dependance

The FTND is a self-report scale consisting of six questions with at least two
possible answers for each question. Each answer has a corresponding score. The total
score is calculated at the end which then gives an indication of an individual's level of
nicotine dependence. There are five levels of nicotine dependence that an individual
can fall into: very low dependence, low dependence, medium dependence, high
dependence, and very high dependence. The FTND has been validated for adult
populations and has acceptable construct validity, test-retest reliability, and internal
consistency (Fauzia, 2005).
Depression Anxiety and Stress Scale

The DASS consists of a set of three self-report scales designed to measure the
emotional states of depression, anxiety and stress. It is a 42-item scale in total, with a
4-point Iikert response format measuring the severity/frequency to which an
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individual has experienced certain states over the past week. Each of the three scales
contains 14 items which are divided into subscales of2-5 items with similar content.
The scales of the DASS have been found to have high internal consistency and to
yield meaningful discriminations in a variety of settings (Psychology Foundation of
Australia, 2006).
Participants

The participants were 30 adults aged 18 years or older, who were living in a
TC for alcohol and other drug rehabilitation.
Procedure

The proposed research was conducted with the assistance and approval of
Cyrenian House Therapeutic Community (see Appendix E). In addition, the research
had Edith Cowan University ethics clearance. Residents were given the information
sheet outlining the nature and purpose of the research (see Appendix D), and were
then given a package containing the three questionnaires which took approximately 30
minutes to complete. A box was provided for residents to place completed
questionnaires into over the next week and they were informed of the researcher's
availability to answer any questions or help with any problems they might encounter.
Residents were informed that participation was not compulsory and that they would
be able to withdraw from the study at any time without prejudice. In addition, all
participants remained anonymous.
Correlation Analysis

The questionnaire data was entered into SPSS for Windows (Version 12.0),
(Coakes, 2005) and a Pearson product-moment correlation coefficient (Pearson's r)
was conducted between the level of nicotine dependence and levels of anxiety,
depression and stress. This allowed for any relationship among the variables to be
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identified. In addition, Cross tabulations using Spearman Rho were performed
between the non continuous variables, and the continuous and non continuous
variables.
Results
The intercorrelations of all the variables are shown in Table I along with the
means and standard deviations of the continuous variables. There were no significant
correlations found between nicotine dependence and anxiety and depression. A
moderate significant positive correlation was found between nicotine dependence and
stress. There was a significant moderate positive correlation found between
participants' stage of change and whether they want to smoke. There was also a
significant moderate-to-strong positive correlation found between participants' stage
of change and how much entering the TC motivated them to quit smoking. In
addition, there was a significant strong negative correlation found between
participants' stage of change and whether they would use quit support if it was offered
to them during their stay in the TC. A significant moderate positive correlation was
also found between participants' age of first cigarette used and participants' age of
first smoking daily. Moreover, significant moderate positive correlations were found
between education and participants' age of first cigarette and participants' age of first
smoking daily. Additionally, there was also a significant weak positive correlation
found between education and having ever smoked.
Group Comparison Analysis

A oneway analysis ofvariance (ANOVA) was conducted using SPSS for
Windows (Versionl2.0) to determine the influence of whether participants drug of
choice influenced their anxiety, depression and stress scores. The main effect for
depression was not significant, F(l, 29) = O.Ol,p > .05. The main effect for anxiety
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was not significant, F(l, 29) = 0.46,p > .05. The main effect for stress was also not
significant, F(l, 29) = 0.59,p > .05.
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Discussion
The present study aimed to test the research question: Do symptoms of anxiety,
depression and stress increase as nicotine dependence increases? It was hypothesised that
as the level of nicotine dependence increases, symptoms of anxiety, depression and stress
will also increase. The findings of the present study only partially support the hypothesis.
There was a moderate significant positive relationship found between nicotine
dependence and stress. This finding is consistent with previous research that has shown
that smoking actually exacerbates stress and that more dependent smokers are more
stressed (Parrot & Garnham, 1998; Parrot, 1993; Parrot, 1994a; Parrot, 1994b). Previous
research has found that, contrary to commonly held beliefs in the addictions field,
smoking cessation amongst people in alcohol and other drug treatment does not
jeopardise their treatment and has actually shown to improve treatment outcomes (Bobo
et al., 1998; Martinet al., 1997; Burling et al., 1991). The present study showed that the
more nicotine dependent individuals were in the TC, the more likely they were to have
higher stress levels. Previous research has shown that ceasing smoking actually results in
a decrease in stress levels for the abstaining smoker (Carey et al., 1993; Cohen and
Lichtenstein, 1990; Parrot, 1995). Therefore, ifthe residents were ceasing smoking
during their stay in the TC they may have lower stress levels and consequently may be
better equipped to achieve successful treatment outcomes.
Previous research has found that the more dependent an individual is on nicotine,
the more they will report they rely on smoking for stress release (Parrot, 1994b). The
present study supports this research. There was a significant moderate negative
relationship found between nicotine dependence and whether an individual thinks that
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smoking decreases their stress levels. This indicated that the more dependent participants
were on smoking, the more likely they were to answer 'yes' to the whether they think
smoking decreases their stress levels. All the participants apart from one who scored five
or more on the nicotine dependence scale said they thought smoking decreases their
stress levels. In contrast, out of the five people who scored less than five on the nicotine
dependence scale, only two answered 'yes' and three answered 'no'. In addition to this,
there was a significant moderate relationship found between participants' age of first
smoking daily and whether they think smoking decreases their stress levels. This
indicates that the younger participants were when they started smoking daily, the more
likely they are to rely on smoking for stress release, suggesting that they are generally
more stressed.
Although there was a relationship found between nicotine dependence and stress,
there were no significant relationships found between nicotine dependence and
depression and anxiety. It is unclear why there was no relationship between nicotine
dependence and anxiety or depression. One possible explanation is that much of the
education that is delivered in the TC is based on cognitive-behavioural therapy (CBT),
which teaches techniques around reducing these symptoms. The lower scores for anxiety
and depression in comparison to stress could be attributable to the residents using CBT
effectively. In addition to this, it could also be that the participants in the TC were in a
positive frame of mind because their lives are heading in a better direction by being a part
of the TC, therefore reporting lower depressive and anxiety symptoms.
The non significant results from the ANOVA indicate that there was not a
significant difference between the anxiety, depression and stress scores of people who
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had entered the TC dependent on alcohol and people who were dependent on alcohol
and/or other drugs. Nonetheless, the present study demonstrated that the residents of the
TC in general, experience higher levels of affective distress than that of the general
population. The means from a sample of 2914 adults from the general population on
measures of depression, anxiety, and stress were 6.34, 4.70, and 10.11 respectively
(Lovibond & Lovibond, 1995). The means for depression, anxiety and stress from the
present study were 13.43, 12.33, and 17.63 respectively. The mean for depression fell
into the mild category, the mean for anxiety fell into the moderate category and the mean
for stress fell into the mild category. Stress scores were the highest out of the three
scores. This is consistent with the measure with the cut-offs for the different categories
being the highest for stress followed by depression and then anxiety.
Previous research has found rates of smoking among individuals with substance
use disorders to be double to triple that of the general community (Batel, Pessione, Maitre
& Rueff, 1995). The first results ofthe NDSHS revealed that in 2007, 16.6% ofthe

population aged 14 years or older reported smoking daily (AIHW, 2007). The present
study found that 90% of participants were smoking daily. Although the participants in the
present study were aged 18 years or older and the population included in the NDSHS
were aged 14 years or older, this finding is still important and supports past research that
has suggested that the rates of smoking are much higher amongst individuals with
substance use disorders than that of the general community.
Support for the "stages of change" theory came from the present study. There was
a significant moderate positive relationship found between participants' stage of change
and whether they want to smoke presently. This indicates that the participants in the
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earlier stages of change were more likely to want to smoke and the participants in the
later stages of change were less likely to want to smoke, supporting the concept that when
people are in precontemplation they can be regarded as 'happy users' (Prochaska &
Velicer, 1997). In addition, there was a significant strong positive relationship between
participants' stage of change and how much entering the TC motivated them to quit
smoking. This indicates that for the individuals in the early stages of change, entering the
TC was less likely to motivate them to quit smoking, and for the individuals in the later
stages of change, entering the TC was more likely to motivate them to quit smoking.
Furthermore, there was a significant strong negative relationship found between
participants' stage of change and whether they would use quit support if it was offered to
them during their stay in the TC. This indicates that the participants in the later stages of
change were much more likely to utilise quit support if offered to them during their stay
in the TC. These findings support the idea that people in the later stages of change are
more consciously thinking about quitting smoking and are consistent with previous
research regarding the stages of change theory (Brogan, Prochaska and Prochaska, 1999;
DiClemente et al., 1991; Pearlman, Wernicke, Thorndike and Haaga, 2004; Prochaska et
al., 1994; Prochaska, Velicer, Fava, Rossi and Tsoh, 2001).
Although weak, a significant negative relationship was found between
participants' stage of change and nicotine dependence. This indicated that participants in
the later stages of change tended to have lower scores on the nicotine dependence scale
suggesting that it may be easier for these individuals to be thinking about or planning on
quitting if their nicotine dependence is not so high. The relationship may also be a result
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of these individuals smoking less in preparation for quitting smoking and therefore
having a lower level of nicotine dependence.
There was a significant moderate positive relationship found between age of first
cigarette and age of starting smoking daily. This finding indicates that the older
participants were when they tried their first cigarette, the older they were when they
started smoking daily. For example, a large proportion of the participants that tried their
first cigarette between ages 10-14, started smoking daily between ages 14-18. There was
also a weak significant negative relationship found between age of starting smoking daily
and stress, as well as a weak significant negative relationship found between age of
starting smoking daily and anxiety. This indicates that as age of starting smoking daily
increases, stress and anxiety decreases. Therefore, the younger participants were when
they had taken up smoking regularly, the more likely they were to have high stress and
anxiety levels presently. This is in line with previous research that suggests that taking up
regular smoking at a young age can have worse mental health outcomes than taking up
regular smoking at an older age (Hirschman et al., 1984; Johnson et al., 2000). Further
supporting these findings was the significant moderate positive relationship found
between participants' age of starting smoking daily and whether they think that smoking
decreases their stress levels. This relationship indicates that the older participants were
when they started smoking daily the more likely they were to report that they do not think
that smoking decreases their stress levels. These findings highlight the importance of
preventing youth from experimenting with smoking.
Research has found socioeconomic status and education level to be a predictor of
smoking, as well as a predictor of success at smoking cessation (Blakey & Wilson, 2005;
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Foulds et al., 2006; Kestila et al., 2006). The findings from the present study support
previous research. Significant moderate positive relationships were found between
education and participants' age of first cigarette use and age of first smoking daily,
indicating that the higher the level of education obtained by participants, the older they
were more likely to be when they tried their first cigarette and when they started smoking
daily. In addition, there was also a significant weak positive correlation found between
education and participants having ever smoked, indicating that the higher the level of
education obtained by participants, the less likely they were to have ever smoked. This
could also be seen from screening the data: both never smokers being two of only five
participants who had university degrees. Interestingly, in addition to this, one ofthe other
three participants that had a university degree only had a score of one on the nicotine
dependence scale. Previous research has suggested that the effect of socioeconomic
background on smoking is a result ofthe social environment of those with a lower
socioeconomic background (Foulds et al., 2006). For example, those with a lower
socioeconomic background are less likely to work in smoke-free environments and are
more likely to have friends and family who smoke. This is likely the case for the present
study.
Previous research has shown NRT to be an effective strategy to assist people to
quit smoking (Gold et al., 2002; Jorenby, 2001; Silagy et al., 1994). The findings from
the present study further support past research. It was found that of the 13 people that had
used NRT in the past, nine of those found NRT to be effective in helping to quit smoking.
However, all of these individuals were currently smoking so therefore the NRT did not
have a lasting effect which is also consistent with previous research (Silagy et al.). The

Smoking, Mental Health, and AOD Treatment 55
next most common strategy that people had used in the past was asking their doctor for
help to quit. However, of the seven people who did this only three said that it had been
effective. This is also in line with previous research that has found brief interventions
delivered by doctors to be ineffective in helping people to quit (Hajek et al., 2002;
Murray et al., 2008).
Participants were also asked what had motivated them to quit smoking in the past.
The most common answers were 'it was costing too much money', 'I wanted to get fit',
'it was affecting my fitness', as well as 'I was pregnant or wanting to start a family'.
These answers were markedly more frequent than the health warnings or quit
advertisements on TV answers. This information could be useful in the development of
strategies to motivate people to quit smoking.
When asked why they don't intend to quit the most frequent answer given by
participants was 'I am addicted to nicotine' followed closely by 'I enjoy smoking' and
'smoking relaxes me'. This is consistent with previous research that has found that
smokers indicate that smoking relaxes them and that they enjoy smoking (Ikard et al.,
1969). This further supports the concept that smoking contributes to stress levels in the
smoker, in that their general stress levels are higher and smoking brings their stress levels
back to the same as a non smoker's general stress levels (Parrot, 1993; Parrot, 1994a;
Parrot, 1994b). However, smoking is more likely to contribute to high stress levels than it
is to relieving stress. Smokers probably perceive smoking to relieve their stress because
they get relief almost immediately when they light a cigarette. But this relief is more
likely to be related to nicotine levels in the blood being increased as soon as a cigarette is
lit (i.e. with the first puff). So what smokers perceive as stress relief is actually relief
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from the feeling they get when they have gone without a cigarette for a period oftime.
This is a result of the physical dependence that occurs from nicotine use.
Findings of importance for Cyrenian House include the finding regarding
participants' views towards quit support. Of the participants that responded to the
question, 48.1% indicated that they would use quit support if it were offered to them
during their stay in the TC. This finding goes against the commonly held belief that
people seeking AOD treatment are only interested in dealing with their AOD
dependencies and do not want to address their smoking. The relationship found between
participants' stage of change and whether they would use quit support also suggests that a
large proportion ofthe other 51.9% who indicated that they would not use quit support
are likely part ofthe 57.1% ofparticipants that were in precontemplation. Therefore,
these individuals could be given education to move them into preparation and then could
be offered quit support by way ofNRT. In addition, there was a significant moderate
positive relationship found between whether participants want to smoke and how much
entering the TC motivated them to quit smoking, indicating that the participants that
reported not wanting to smoke were more likely to report that entering the TC motivated
them to quit smoking. There was also a significant moderate negative relationship found
between how much entering the TC motivated participants to quit smoking and whether
they would use quit support if offered to them. This indicates that the participants who
reported being motivated to quit smoking would be more likely to use quit support if it
was offered to them. Moreover, a significant moderate positive relationship was also
found between whether participants would use quit support if offered to them and the
effect that having one smoking area in the TC would have on their smoking. This
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indicates that those who reported that they would not use quit support were more likely to
report that having one smoking area in the TC would reduce their smoking largely.
Other noteworthy findings include the significant negative moderate relationship
found between age and anxiety, indicating that the younger the participants were the
more likely they were to have higher anxiety scores. Moreover, there was a significant
negative moderate relationship also found between length of stay and anxiety, indicating
that the less time participants had been residents of the TC the more likely they were to
have higher anxiety scores. This finding stands to reason, in that people would be more
anxious in their first few weeks of entering 'a rehabilitation program, whether from
experiencing withdrawal symptoms or from adjusting to a foreign environment.
There are some limitations with the present study. Firstly, all data was gathered
via self-report so it could not be certain that participants answered all questions honestly.
Secondly, participants in a residential drug rehabilitation setting are likely to experience
negative affect due to withdrawal from alcohol and other drugs. This may have
influenced the participants' scores on the DASS instrument. Finally, a sample size of
more than 30 participants would have been desirable. However, there are normally only
25 to 30 residents staying in the TC at any one time and due to the unique nature of the
setting it was not feasible to recruit participants from other residential rehabilitation
centres. The fact that all participants were from Cyrenian House TC was also a strength
of the present study. The findings may inform Cyrenian House as to the most appropriate
action to undertake regarding smoking cessation and intervention. Another strength of the
study was the measure of the effect of nicotine on mental health. Most other studies on
the effect of nicotine on mental health symptoms have not been conducted on individuals
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living in a TC for alcohol and other drug rehabilitation. Residents of the TC are not
permitted to use alcohol or other drugs that are not prescribed during their stay. In
contrast, other studies would likely not have been able to control for their participants
using alcohol or other drugs and therefore may have had results that were influenced by
their participants using alcohol or other drugs. Therefore, in this sense, the present study
is a more pure measure ofthe effect of nicotine on mental health.
In conclusion, the findings from the present study suggest that smoking may be
contributing to the TC residents' stress levels. Therefore, if smoking intervention can
reduce symptoms of stress for residents it may result in better treatment outcomes. For
those residents assessed as being in the early stages of change, interventions could focus
on moving residents through the stages of change before incorporating smoking
cessation. Interventions could include education around the negative health consequences
of smoking as well as education around the less commonly known mental health
problems associated with smoking. In addition, the education could also incorporate
some stress management techniques. Residents assessed as being ready to change their
smoking behaviour, along with residents who have received intervention, could be
offered smoking cessation, with the aid ofNRT. This may result in lower symptoms of
stress due to the fact they would be receiving a consistent amount of nicotine throughout
the day instead of intermittent periods ofheavy smoking. To incorporate smoking
intervention and cessation into the TC program and assess residents' symptoms of
anxiety, depression and stress pre and post intervention and cessation would be a useful
direction for future research.
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Appendix A
Please answer all questions that apply to you and use the tick boxes where provided.
1. What is your age? 18-25 D

25-35 D

2. What is your sex? M D

F D

35-45 D

over 45 D

3. What is your level of formal education? (Please tick box, mark all that apply)
finished primary school D

finished year 10 at secondary school D

finished year 12 at secondary school D

completed TAFE course D

oth~r

completed university degree D

D

4. How long have you been living at Cyrenian House? 0-4 weeks D
8-12 weeks D

12-16 weeks D

16-20 weeks D

4-8 weeks D

over 20 weeks D

5. What was your main drug of concern for entering Cyrenian House? Alcohol D
cannabis D

heroin D

amphetamines D

other opiates D

benzos D

6. Do you currently smoke cigarettes? Y D

N D

7. Have you ever smoked cigarettes? Y D

N D (only continue if answer is yes)

8. About what age were you when you smoked your first full cigarette? Under 6 D
6-10 D

10-14 0

14-18 D

over 18 D

9. At what age did you first start smoking on a daily basis? Under 6 D
10-14 D

14-18 D

18-25 D

6-10 D

over 25 D

10. During the last 12 months, did you find that you couldn't stop smoking, even though
you want to or tried to?

Y D

N D

11. During the last 12 months, did you find that you couldn't cut down on your smoking,
even though you want to or tried to?

Y 0

N D
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12. Do you want to smoke now?

Y 0

N 0

13. In the past have you .... ? (tick all that apply)
Given up smoking (for more than a month) 0
Tried to give up unsuccessfully 0
Changed to a brand with lower tar or nicotine content 0
Tried to change to a brand with lower tar or nicotine content, but unsuccessfully 0
Reduced the amount of tobacco you smoke in a day 0
Tried to reduce the amount of tobacco you smoke in a day, but unsuccessfully 0
None of these 0 (skip to question 20)
14. Which of the following motivated you to try giving up, cutting down or changing to a
lower tar or nicotine brand? (tick all that apply)
Health warnings on cigarette packets 0
Quit advertisements on radio 0

Quit advertisements on TV 0

Quit advertisements in newspapers etc 0

Advertisements for nicotine replacement products eg nicotine gum, patches, Zyban 0
QUIT line (phone number on cigarette packet) 0
I wanted to get fit 0

I was pregnant or wanting to start a family 0

I thought it was affecting my health or fitness 0

My doctor advised me to give up 0

Family and/or friends asked me to quit 0
I was worried it was affecting the health of those around me 0

It was costing too much money 0
Smoking bans in public areas (e.g. restaurants, sporting venues etc.) U
Smoking bans at work 0

Other 0

15. Do you plan on giving up smoking .... ?
Not in the next 6 months 0

in the next 6 months 0

I quit smoking within the last 6 months 0

in the next month 0

I quit smoking over 6 months ago 0
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Discussion
The present study aimed to test the research question: Do symptoms of anxiety,
depression and stress increase as nicotine dependence increases? It was hypothesised that
as the level of nicotine dependence increases, symptoms of anxiety, depression and stress
will also increase. The findings of the present study only partially support the hypothesis.
There was a moderate significant positive relationship found between nicotine
dependence and stress. This finding is consistent with previous research that has shown
that smoking actually exacerbates stress and that more dependent smokers are more
stressed (Parrot & Garnham, 1998; Parrot, 1993; Parrot, 1994a; Parrot, 1994b). Previous
research has found that, contrary to commonly held beliefs in the addictions field,
smoking cessation amongst people in alcohol and other drug treatment does not
jeopardise their treatment and has actually shown to improve treatment outcomes (Bobo
et al., 1998; Martinet al., 1997; Burling et al., 1991). The present study showed that the
more nicotine dependent individuals were in the TC, the more likely they were to have
higher stress levels. Previous research has shown that ceasing smoking actually results in
a decrease in stress levels for the abstaining smoker (Carey et al., 1993; Cohen and
Lichtenstein, 1990; Parrot, 1995). Therefore, ifthe residents were ceasing smoking
during their stay in the TC they may have lower stress levels and consequently may be
better equipped to achieve successful treatment outcomes.
Previous research has found that the more dependent an individual is on nicotine,
the more they will report they rely on smoking for stress release (Parrot, 1994b). The
present study supports this research. There was a significant moderate negative
relationship found between nicotine dependence and whether an individual thinks that
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smoking decreases their stress levels. This indicated that the more dependent participants
were on smoking, the more likely they were to answer 'yes' to the whether they think
smoking decreases their stress levels. All the participants apart from one who scored five
or more on the nicotine dependence scale said they thought smoking decreases their
stress levels. In contrast, out of the five people who scored less than five on the nicotine
dependence scale, only two answered 'yes' and three answered 'no'. In addition to this,
there was a significant moderate relationship found between participants' age of first
smoking daily and whether they think smoking decreases their stress levels. This
indicates that the younger participants were when they started smoking daily, the more
likely they are to rely on smoking for stress release, suggesting that they are generally
more stressed.
Although there was a relationship found between nicotine dependence and stress,
there were no significant relationships found between nicotine dependence and
depression and anxiety. It is unclear why there was no relationship between nicotine
dependence and anxiety or depression. One possible explanation is that much of the
education that is delivered in the TC is based on cognitive-behavioural therapy (CBT),
which teaches techniques around reducing these symptoms. The lower scores for anxiety
and depression in comparison to stress could be attributable to the residents using CBT
effectively. In addition to this, it could also be that the participants in the TC were in a
positive frame of mind because their lives are heading in a better direction by being a part
of the TC, therefore reporting lower depressive and anxiety symptoms.
The non significant results from the ANOVA indicate that there was not a
significant difference between the anxiety, depression and stress scores of people who
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had entered the TC dependent on alcohol and people who were dependent on alcohol
and/or other drugs. Nonetheless, the present study demonstrated that the residents of the
TC in general, experience higher levels of affective distress than that of the general
population. The means from a sample of 2914 adults from the general population on
measures of depression, anxiety, and stress were 6.34, 4.70, and 10.11 respectively
(Lovibond & Lovibond, 1995). The means for depression, anxiety and stress from the
present study were 13.43, 12.33, and 17.63 respectively. The mean for depression fell
into the mild category, the mean for anxiety fell into the moderate category and the mean
for stress fell into the mild category. Stress scores were the highest out of the three
scores. This is consistent with the measure with the cut-offs for the different categories
being the highest for stress followed by depression and then anxiety.
Previous research has found rates of smoking among individuals with substance
use disorders to be double to triple that of the general community (Batel, Pessione, Maitre
& Rueff, 1995). The first results ofthe NDSHS revealed that in 2007, 16.6% ofthe

population aged 14 years or older reported smoking daily (AIHW, 2007). The present
study found that 90% of participants were smoking daily. Although the participants in the
present study were aged 18 years or older and the population included in the NDSHS
were aged 14 years or older, this finding is still important and supports past research that
has suggested that the rates of smoking are much higher amongst individuals with
substance use disorders than that of the general community.
Support for the "stages of change" theory came from the present study. There was
a significant moderate positive relationship found between participants' stage of change
and whether they want to smoke presently. This indicates that the participants in the
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earlier stages of change were more likely to want to smoke and the participants in the
later stages of change were less likely to want to smoke, supporting the concept that when
people are in precontemplation they can be regarded as 'happy users' (Prochaska &
Velicer, 1997). In addition, there was a significant strong positive relationship between
participants' stage of change and how much entering the TC motivated them to quit
smoking. This indicates that for the individuals in the early stages of change, entering the
TC was less likely to motivate them to quit smoking, and for the individuals in the later
stages of change, entering the TC was more likely to motivate them to quit smoking.
Furthermore, there was a significant strong negative relationship found between
participants' stage of change and whether they would use quit support if it was offered to
them during their stay in the TC. This indicates that the participants in the later stages of
change were much more likely to utilise quit support if offered to them during their stay
in the TC. These findings support the idea that people in the later stages of change are
more consciously thinking about quitting smoking and are consistent with previous
research regarding the stages of change theory (Brogan, Prochaska and Prochaska, 1999;
DiClemente et al., 1991; Pearlman, Wernicke, Thorndike and Haaga, 2004; Prochaska et
al., 1994; Prochaska, Velicer, Fava, Rossi and Tsoh, 2001).
Although weak, a significant negative relationship was found between
participants' stage of change and nicotine dependence. This indicated that participants in
the later stages of change tended to have lower scores on the nicotine dependence scale
suggesting that it may be easier for these individuals to be thinking about or planning on
quitting if their nicotine dependence is not so high. The relationship may also be a result
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of these individuals smoking less in preparation for quitting smoking and therefore
having a lower level of nicotine dependence.
There was a significant moderate positive relationship found between age of first
cigarette and age of starting smoking daily. This finding indicates that the older
participants were when they tried their first cigarette, the older they were when they
started smoking daily. For example, a large proportion of the participants that tried their
first cigarette between ages 10-14, started smoking daily between ages 14-18. There was
also a weak significant negative relationship found between age of starting smoking daily
and stress, as well as a weak significant negative relationship found between age of
starting smoking daily and anxiety. This indicates that as age of starting smoking daily
increases, stress and anxiety decreases. Therefore, the younger participants were when
they had taken up smoking regularly, the more likely they were to have high stress and
anxiety levels presently. This is in line with previous research that suggests that taking up
regular smoking at a young age can have worse mental health outcomes than taking up
regular smoking at an older age (Hirschman et al., 1984; Johnson et al., 2000). Further
supporting these findings was the significant moderate positive relationship found
between participants' age of starting smoking daily and whether they think that smoking
decreases their stress levels. This relationship indicates that the older participants were
when they started smoking daily the more likely they were to report that they do not think
that smoking decreases their stress levels. These findings highlight the importance of
preventing youth from experimenting with smoking.
Research has found socioeconomic status and education level to be a predictor of
smoking, as well as a predictor of success at smoking cessation (Blakey & Wilson, 2005;
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Foulds et al., 2006; Kestila et al., 2006). The findings from the present study support
previous research. Significant moderate positive relationships were found between
education and participants' age of first cigarette use and age of first smoking daily,
indicating that the higher the level of education obtained by participants, the older they
were more likely to be when they tried their first cigarette and when they started smoking
daily. In addition, there was also a significant weak positive correlation found between
education and participants having ever smoked, indicating that the higher the level of
education obtained by participants, the less likely they were to have ever smoked. This
could also be seen from screening the data: both never smokers being two of only five
participants who had university degrees. Interestingly, in addition to this, one ofthe other
three participants that had a university degree only had a score of one on the nicotine
dependence scale. Previous research has suggested that the effect of socioeconomic
background on smoking is a result ofthe social environment of those with a lower
socioeconomic background (Foulds et al., 2006). For example, those with a lower
socioeconomic background are less likely to work in smoke-free environments and are
more likely to have friends and family who smoke. This is likely the case for the present
study.
Previous research has shown NRT to be an effective strategy to assist people to
quit smoking (Gold et al., 2002; Jorenby, 2001; Silagy et al., 1994). The findings from
the present study further support past research. It was found that of the 13 people that had
used NRT in the past, nine of those found NRT to be effective in helping to quit smoking.
However, all of these individuals were currently smoking so therefore the NRT did not
have a lasting effect which is also consistent with previous research (Silagy et al.). The
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next most common strategy that people had used in the past was asking their doctor for
help to quit. However, of the seven people who did this only three said that it had been
effective. This is also in line with previous research that has found brief interventions
delivered by doctors to be ineffective in helping people to quit (Hajek et al., 2002;
Murray et al., 2008).
Participants were also asked what had motivated them to quit smoking in the past.
The most common answers were 'it was costing too much money', 'I wanted to get fit',
'it was affecting my fitness', as well as 'I was pregnant or wanting to start a family'.
These answers were markedly more frequent than the health warnings or quit
advertisements on TV answers. This information could be useful in the development of
strategies to motivate people to quit smoking.
When asked why they don't intend to quit the most frequent answer given by
participants was 'I am addicted to nicotine' followed closely by 'I enjoy smoking' and
'smoking relaxes me'. This is consistent with previous research that has found that
smokers indicate that smoking relaxes them and that they enjoy smoking (Ikard et al.,
1969). This further supports the concept that smoking contributes to stress levels in the
smoker, in that their general stress levels are higher and smoking brings their stress levels
back to the same as a non smoker's general stress levels (Parrot, 1993; Parrot, 1994a;
Parrot, 1994b). However, smoking is more likely to contribute to high stress levels than it
is to relieving stress. Smokers probably perceive smoking to relieve their stress because
they get relief almost immediately when they light a cigarette. But this relief is more
likely to be related to nicotine levels in the blood being increased as soon as a cigarette is
lit (i.e. with the first puff). So what smokers perceive as stress relief is actually relief
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from the feeling they get when they have gone without a cigarette for a period oftime.
This is a result of the physical dependence that occurs from nicotine use.
Findings of importance for Cyrenian House include the finding regarding
participants' views towards quit support. Of the participants that responded to the
question, 48.1% indicated that they would use quit support if it were offered to them
during their stay in the TC. This finding goes against the commonly held belief that
people seeking AOD treatment are only interested in dealing with their AOD
dependencies and do not want to address their smoking. The relationship found between
participants' stage of change and whether they would use quit support also suggests that a
large proportion ofthe other 51.9% who indicated that they would not use quit support
are likely part ofthe 57.1% ofparticipants that were in precontemplation. Therefore,
these individuals could be given education to move them into preparation and then could
be offered quit support by way ofNRT. In addition, there was a significant moderate
positive relationship found between whether participants want to smoke and how much
entering the TC motivated them to quit smoking, indicating that the participants that
reported not wanting to smoke were more likely to report that entering the TC motivated
them to quit smoking. There was also a significant moderate negative relationship found
between how much entering the TC motivated participants to quit smoking and whether
they would use quit support if offered to them. This indicates that the participants who
reported being motivated to quit smoking would be more likely to use quit support if it
was offered to them. Moreover, a significant moderate positive relationship was also
found between whether participants would use quit support if offered to them and the
effect that having one smoking area in the TC would have on their smoking. This
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indicates that those who reported that they would not use quit support were more likely to
report that having one smoking area in the TC would reduce their smoking largely.
Other noteworthy findings include the significant negative moderate relationship
found between age and anxiety, indicating that the younger the participants were the
more likely they were to have higher anxiety scores. Moreover, there was a significant
negative moderate relationship also found between length of stay and anxiety, indicating
that the less time participants had been residents of the TC the more likely they were to
have higher anxiety scores. This finding stands to reason, in that people would be more
anxious in their first few weeks of entering 'a rehabilitation program, whether from
experiencing withdrawal symptoms or from adjusting to a foreign environment.
There are some limitations with the present study. Firstly, all data was gathered
via self-report so it could not be certain that participants answered all questions honestly.
Secondly, participants in a residential drug rehabilitation setting are likely to experience
negative affect due to withdrawal from alcohol and other drugs. This may have
influenced the participants' scores on the DASS instrument. Finally, a sample size of
more than 30 participants would have been desirable. However, there are normally only
25 to 30 residents staying in the TC at any one time and due to the unique nature of the
setting it was not feasible to recruit participants from other residential rehabilitation
centres. The fact that all participants were from Cyrenian House TC was also a strength
of the present study. The findings may inform Cyrenian House as to the most appropriate
action to undertake regarding smoking cessation and intervention. Another strength of the
study was the measure of the effect of nicotine on mental health. Most other studies on
the effect of nicotine on mental health symptoms have not been conducted on individuals
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living in a TC for alcohol and other drug rehabilitation. Residents of the TC are not
permitted to use alcohol or other drugs that are not prescribed during their stay. In
contrast, other studies would likely not have been able to control for their participants
using alcohol or other drugs and therefore may have had results that were influenced by
their participants using alcohol or other drugs. Therefore, in this sense, the present study
is a more pure measure ofthe effect of nicotine on mental health.
In conclusion, the findings from the present study suggest that smoking may be
contributing to the TC residents' stress levels. Therefore, if smoking intervention can
reduce symptoms of stress for residents it may result in better treatment outcomes. For
those residents assessed as being in the early stages of change, interventions could focus
on moving residents through the stages of change before incorporating smoking
cessation. Interventions could include education around the negative health consequences
of smoking as well as education around the less commonly known mental health
problems associated with smoking. In addition, the education could also incorporate
some stress management techniques. Residents assessed as being ready to change their
smoking behaviour, along with residents who have received intervention, could be
offered smoking cessation, with the aid ofNRT. This may result in lower symptoms of
stress due to the fact they would be receiving a consistent amount of nicotine throughout
the day instead of intermittent periods ofheavy smoking. To incorporate smoking
intervention and cessation into the TC program and assess residents' symptoms of
anxiety, depression and stress pre and post intervention and cessation would be a useful
direction for future research.
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Appendix A
Please answer all questions that apply to you and use the tick boxes where provided.
1. What is your age? 18-25 D

25-35 D

2. What is your sex? M D

F D

35-45 D

over 45 D

3. What is your level of formal education? (Please tick box, mark all that apply)
finished primary school D

finished year 10 at secondary school D

finished year 12 at secondary school D

completed TAFE course D

oth~r

completed university degree D

D

4. How long have you been living at Cyrenian House? 0-4 weeks D
8-12 weeks D

12-16 weeks D

16-20 weeks D

4-8 weeks D

over 20 weeks D

5. What was your main drug of concern for entering Cyrenian House? Alcohol D
cannabis D

heroin D

amphetamines D

other opiates D

benzos D

6. Do you currently smoke cigarettes? Y D

N D

7. Have you ever smoked cigarettes? Y D

N D (only continue if answer is yes)

8. About what age were you when you smoked your first full cigarette? Under 6 D
6-10 D

10-14 0

14-18 D

over 18 D

9. At what age did you first start smoking on a daily basis? Under 6 D
10-14 D

14-18 D

18-25 D

6-10 D

over 25 D

10. During the last 12 months, did you find that you couldn't stop smoking, even though
you want to or tried to?

Y D

N D

11. During the last 12 months, did you find that you couldn't cut down on your smoking,
even though you want to or tried to?

Y 0

N D
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12. Do you want to smoke now?

Y 0

N 0

13. In the past have you .... ? (tick all that apply)
Given up smoking (for more than a month) 0
Tried to give up unsuccessfully 0
Changed to a brand with lower tar or nicotine content 0
Tried to change to a brand with lower tar or nicotine content, but unsuccessfully 0
Reduced the amount of tobacco you smoke in a day 0
Tried to reduce the amount of tobacco you smoke in a day, but unsuccessfully 0
None of these 0 (skip to question 20)
14. Which of the following motivated you to try giving up, cutting down or changing to a
lower tar or nicotine brand? (tick all that apply)
Health warnings on cigarette packets 0
Quit advertisements on radio 0

Quit advertisements on TV 0

Quit advertisements in newspapers etc 0

Advertisements for nicotine replacement products eg nicotine gum, patches, Zyban 0
QUIT line (phone number on cigarette packet) 0
I wanted to get fit 0

I was pregnant or wanting to start a family 0

I thought it was affecting my health or fitness 0

My doctor advised me to give up 0

Family and/or friends asked me to quit 0
I was worried it was affecting the health of those around me 0

It was costing too much money 0
Smoking bans in public areas (e.g. restaurants, sporting venues etc.) U
Smoking bans at work 0

Other 0

15. Do you plan on giving up smoking .... ?
Not in the next 6 months 0

in the next 6 months 0

I quit smoking within the last 6 months 0

in the next month 0

I quit smoking over 6 months ago 0
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16. Why don't you intend to quit? (Please tick all that apply)
I enjoy smoking D

smoking relaxes me D

I am addicted to nicotine D

smoking is not as bad for my health as people say D
smoking helps manage my weight D

other D

17. Do you think that smoking decreases your stress levels? Y D

N D

18. What would motivate you to quit? (Please tick all that apply)
Advice from my doctor D
ill health D

family/parents/partner D

pregnancy D

children in the home D

affecting my fitness D
other D

19. During the last twelve months have you done any of the following? (tick all that
apply)
Rung the 'QUIT' line D

Asked your doctor for help to quit D

Used nicotine gum, nicotine patch or nicotine inhaler D
Used a smoking cessation pill D
Bought a product other than nicotine patch, gum or pill to help you quit D
Read 'how to quit' literature D

Used the internet to help you quit D

Done something else to help you quit D

None ofthe above D

Don'tknow D
20. If so, please tick any of the following that you found to be effective
Rung the 'QUIT' line D

Asked your doctor for help to quit D

Used nicotine gum, nicotine patch or nicotine inhaler D
Used a smoking cessation pill D
Bought a product other than nicotine patch, gum or pill to help you quit D
Read 'how to quit' literature D

Used the internet to help you quit D

Don'tknow D
21. To what extent has entering Cyrenian House motivated you to give up smoking?
Not at all' D

not sure D

very much D
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22. What impact do you think having only one designated smoking area at Cyrenian
House would have on your smoking?
Reduce it slightly D

Reduce it largely D

No impact D

23. Would you attempt to quit smoking during your stay at Cyrenian House if quit
support was offered to you? Y D

N D
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AppendixB

Fagerstrom Test for Nicotine Dependence *
Please answer the following questions by ticking the appropriate box.
1. How soon after you wake up do you smoke your first cigarette?
+ After 60 minutes D
(0)
+ 31-60 minutes D
(1)
+ 6-30 minutes D
(2)
+ Within 5 minutes D
(3)
2. Do you find it difficult to refrain from smoking in places where it is forbidden?

+NoD
(0)
+Yes D
(1)
3. Which cigarette would you hate most to give up?
+ The first in the morning D
(1)
+Any other D
(0)
4. How many cigarettes per day do you smoke?
+ 10 or less D
(0)
+11-20 D
(1)
+ 21-30 D
(2)
+ 31 or more D
(3)
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Please answer the following questions by ticking the appropriate box
5. Do you smoke more frequently during the first hours after awakening than during the
rest of the day?
+NoD
(0)
+Yes D
(1)
6. Do you smoke even if you are so ill that you are in bed most of the day?
+NoD
(0)
+Yes D
(1)
* Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagerstrom Test for
Nictoine Dependence: A revision of the Fagerstrom Tolerance Questionnaire. British
Journal of Addictions 1991;86:1119-27
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Appendix C

DASS

Name:

Date:

Please read each statement and circle a number 0, 1, 2 or 3 which indicates how much the statement
applied to you over the past week. There are no right or wrong answers. Do not spend too much time ,
on any statement.
!

The rating scale is as follows:
0
1
2
3

Did not apply to me at all
Applied to me to some degree, or some of the time
Applied to me to a considerable degree, or a good part of time
Applied to me very much, or most of the time

1

I found myself getting upset by quite trivial things

0

1

2

3

2

I was aware of dryness of my mouth

0

1

2

3

3

I couldn't seem to experience any positive feeling at all

0

1

2

3

4

I experienced breathing difficulty (eg, excessively rapid breathing,
breathlessness in the absence of physical exertion)

0

1

2

3

5

I just couldn't seem to get going

0

1

2

3

6

I tended to over-react to situations

0

1

2

3

7

I had a feeling of shakiness (eg, legs going to give way)

0

1

2

3

8

I found it difficult to relax

0

1

2

3

9

I found myself in situations that made me so anxious I was most
relieved when they ended

0

1

2

3

10

I felt that I had nothing to look forward to

0

1

2

3

11

I found myself getting upset rather easily

0

1

2

3

12

I felt that I was using a lot of nervous energy

0

1

2

3

13

I felt sad and depressed

0

1

2

3

14

I found myself getting impatient when I was delayed in any way
(eg, lifts, traffic lights, being kept waiting)

0

1

2

3

15

I had a feeling of faintness

0

1

2

3

16

I felt that I had lost interest in just about everything

0

1

2

3

17

I felt I wasn't worth much as a person

0

1

2

3

18

I felt that I was rather touchy

0

1

2

3
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19

I perspired noticeably (eg, hands sweaty) in the absence of high
temperatures or physical exertion

0

1

2

3

20

I felt scared without any good reason

0

1

2

3

21

I felt that life wasn't worthwhile

0

1

2

3
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Reminder of rating scale:

0
1
2
3

Did not apply to me at all
Applied to me to some degree, or some of the time
Applied to me to a considerable degree, or a good part of time
Applied to me very much, or most of the time

22

I found it hard to wind down

0

1

2

3

23

I had difficulty in swallowing

0

1

2

3

24

I couldn't seem to get any enjoyment out of the things I did

0

1

2

3

25

I was aware of the action of my heart in the absence of physical
exertion (eg, sense of heart rate increase, heart missing a beat)

0

1

2

3

26

I felt down-hearted and blue

0

1

2

3

27

I found that I was very irritable

0

1

2

3

28

I felt I was close to panic

0

1

2

3

29

I found it hard to calm down after something upset me

0

1

2

3

30

I feared that I would be "thrown" by some trivial but
unfamiliar task

0

1

2

3

31

I was unable to become enthusiastic about anything

0

1

2

3

32

I found it difficult to tolerate interruptions to what I was doing

0

1

2

3

33

I was in a state of nervous tension

0

1

2

3

34

I felt I was pretty worthless

0

1

2

3

35

I was intolerant of anything that kept me from getting on with
what I was doing

0

1

2

3

36

I felt terrified

0

1

2

3

37

I could see nothing in the future to be hopeful about

0

1

2

3

38

I felt that life was meaningless

0

1

2

3

39

I found myself getting agitated

0

1

2

3

40

I was worried about situations in which I might panic and make
a fool of myself

0

1

2

3

41

I experienced trembling (eg, in the hands)

0

1

2

3

42

I found it difficult to work up the initiative to do things

0

1

2

3

Smoking, Mental Health, and AOD Treatment 75
Appendix D

Information Letter
The Relationship between Nicotine Dependence and Symptoms ofAnxiety,
Depression and Stress in a Therapeutic Community for Alcohol and other Drug
Rehabilitation
(Edith Cowan University)
Dear Participant,
My name is Thomas Hopkins. I am conducting research on the relationship between
nicotine dependence and symptoms of anxiety, depression and stress in a Therapeutic
Community for alcohol and other drug rehabilitation. I would like to invite you to
participate in my study, its findings may provide a better understanding of the
relationship between smoking and mental health.
You will be asked to complete three questionnaires regarding personal characteristics,
smoking, anxiety, depression and stress which should approximately take 30 minutes.
Participation in this study is voluntary and you will be able to withdraw at any time. The
information gathered will remain anonymous. The service provided to you will not be
affected in any way if you choose not to participate in the study. No persons beside my
supervisor and I will have access to the research data. Counselling services are available
to all participants through Edith Cowan University Psychological Services Centre on
9301 0011, as well as a 24 hour counselling service through Lifeline on 13 1114.
This research project is being undertaken as part of the requirements of an Honours
program at Edith Cowan University.

Kind regards,

Thomas Hopkins
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AppendixE
Letter of Approval

I have read through the proposed research and am fully aware of the nature and purpose
ofthe research. I support the use of residents ofCyrenian House Therapeutic Community
as participants in the proposed research. Whilst I would encourage residents to participate
in the research, the service provided to residents will not be affected in any way if they
choose not to participate.

Carol Daws

Executive Director, Cyrenian House
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